← Legislation / NS132
NS132INTRODUCEDHEALTHNOVA SCOTIA
Fair Drug Pricing Act (amended)
Long title not yet sourced from the legislative registry.
- Sponsor
- —
- Introduced
- —
- Royal assent
- —
- Final vote
- —
Legislative timeline
- 1st—
- 2nd—
- Comm.—
- 3rd—
- Senate—
- Assent—
Bill overview
Bill NS132, “Fair Drug Pricing Act (amended)”, is a Nova Scotia bill from session assembly-64-session-1.
Its latest recorded status is “Introduced”.
This overview is written automatically from the registry and vote records on this page and updates when they sync. It describes the bill's path, not its merits.
PLAIN-LANGUAGE SUMMARY
What you need to know
Status changed: 2022-04-05T00:00:00.000
Key provisions
- 01This Act amends the Fair Drug Pricing Act to require pharmaceutical companies to disclose their pricing strategies.
- 02The Minister of Health must review and report on the effectiveness of the amended Act within 12 months.
- 03Pharmaceutical companies must provide the Minister with detailed financial statements and pricing information.
- 04The Act prohibits the Minister from disclosing confidential business information provided by pharmaceutical companies.
- 05The Minister must establish a committee to monitor and enforce compliance with the amended Act.
- 06The Nova Scotia government must review and update the list of essential medications covered under the amended Act annually.
Vote roll
No division has been recorded for this bill yet.